Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study

Documenti analoghi

• Unusual TSCM‐like cells with poly‐chemokine‐receptor expression in a B‐cell‐depleted survivor of severe COVID‐19
  di: Addi Josua Romero‐Olmedo, et al.
  Pubblicazione: (2024)
• COVID‐19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network‐Based Approach
  di: Carolina Garcia‐Vidal, et al.
  Pubblicazione: (2025)
• Antibody responses to common viruses according to COVID‐19 severity and postacute sequelae of COVID‐19
  di: Marianna Karachaliou, et al.
  Pubblicazione: (2024)
• Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre‐COVID‐19, COVID‐19 pandemic, and post‐COVID‐19 periods
  di: Yanhong Sun, et al.
  Pubblicazione: (2024)
• SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19
  di: Alexi Vasbinder, et al.
  Pubblicazione: (2024)